GCI Trainee Alexandre Poirier Receives the 2024 Prix Acfas Relève – Health Sciences Division

The Prix Acfas Relève recognizes the diversity and richness of the scientific paths taken by our next generation of researchers in Quebec and in Canada. This year, five graduate trainees received this Award at the University of Ottawa, including the Rosalind and Morris Goodman Cancer Institute’s (GCI) Alexandre Poirier. Alex is currently completing his PhD in Experimental Medicine under the supervision of Prof. Michel Tremblay.  

Alexandre Poirier's passion for research began in Dr. Hoang's laboratory at the University of Montreal. This experience shifted his perspectives towards fundamental research. Currently in his fifth year of doctoral studies, he focuses on two major projects: studying the TAOK3 gene in the immune system and investigating the anti-cancer potential of phosphatase inhibitors. Additionally, he dedicates himself to scientific communication to the general public through conferences and initiatives such as DÉSIR/RIOT, a team focused on raising awareness and providing information about research affiliated with the Canadian Cancer Society. He strongly believes in the importance of mentorship, sharing his passion and knowledge with the students he supervises.

Next on his agenda is a postdoctoral fellowship in the United States: he is eager to apply his expertise in immunology to explore the potential of mRNA vaccines in cancer immunotherapy. He set his mind to dedicate this career on studying the intricate mechanisms of mRNA-based immunotherapies, while continuing to encourage future generations to embrace science and advance research.
(Modified from https://www.acfas.ca/prix-concours/prix-acfas/recipiendairesreleve)

Alex shares with us, “This award gives me confidence in the results of my scientific journey and confirms that the diversity of my scientific projects is an asset to the type of researcher I hope to become.”

Congratulations, Alex, on your great achievements!